siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells

Virology

Volumn 346, Issue 2, 2006, Pages 385-393

  Yin, Qinyan ^a   Flemington, Erik K ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EBNA1; EBV; Lymphoma; RNAi; siRNA

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL; VIRUS LATENCY; VIRUS REPLICATION;

B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; PLASMIDS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 33644821804     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.11.021     Document Type: Article

References (28)

1. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 5567 2002 550 553
2. S.P. Buchbinder, S.D. Holmberg, S. Scheer, G. Colfax, P. O'Malley, and E. Vittinghoff Combination antiretroviral therapy and incidence of AIDS-related malignancies J. Acquired Immune Defic. Syndr. 21 Suppl. 1 1999 S23 S26
3. K. Butz, T. Ristriani, A. Hengstermann, C. Denk, M. Scheffner, and F. Hoppe-Seyler siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells Oncogene 22 38 2003 5938 5945
4. A. Calzolari, A. Papucci, G. Baroni, G. Ficarra, B. Porfirio, I. Chiarelli, and S. Di Lollo Epstein-Barr virus infection and P53 expression in HIV-related oral large B cell lymphoma Head Neck 21 5 1999 454 460
5. C. Cayrol, and E.K. Flemington Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1 J. Virol. 69 7 1995 4206 4212
6. M.R. Chen, C.H. Tsai, F.F. Wu, S.H. Kan, C.S. Yang, and J.Y. Chen The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines J. Gen. Virol. 80 Pt. 2 1999 447 455
7. C.L. Dodd, D. Greenspan, M. Schiodt, T.E. Daniels, J.H. Beckstead, L.A. MacPhail, S. Miyasaki, and J.S. Greenspan Unusual oral presentation of non-Hodgkin's lymphoma in association with HIV infection Oral Surg. Oral Med. Oral Pathol. 73 5 1992 603 608
8. Q. Ge, M.T. McManus, T. Nguyen, C.H. Shen, P.A. Sharp, H.N. Eisen, and J. Chen RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription Proc. Natl. Acad. Sci. U.S.A. 100 5 2003 2718 2723
9. T.L. Green, and L.R. Eversole Oral lymphomas in HIV-infected patients: association with Epstein-Barr virus DNA Oral Surg. Oral Med. Oral Pathol. 67 4 1989 437 442
10. A.H. Hall, and K.A. Alexander RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells J. Virol. 77 10 2003 6066 6069
11. M. Heller, E. Flemington, E. Kieff, and P. Deininger Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat Mol. Cell. Biol. 5 3 1985 457 465
12. L.P. Jacobson, T.E. Yamashita, R. Detels, J.B. Margolick, J.S. Chmiel, L.A. Kingsley, S. Melnick, and A. Munoz Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study J. Acquired Immune Defic. Syndr. 21 Suppl. 1 1999 S34 S41
13. J.M. Jacque, K. Triques, and M. Stevenson Modulation of HIV-1 replication by RNA interference Nature 418 6896 2002 435 438
14. M. Jiang, and J. Milner Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs Methods Mol. Biol. 292 2005 401 420
15. S.B. Kapadia, A. Brideau-Andersen, and F.V. Chisari Interference of hepatitis C virus RNA replication by short interfering RNAs Proc. Natl. Acad. Sci. U.S.A. 100 4 2003 2014 2018
16. G. Kennedy, J. Komano, and B. Sugden Epstein-Barr virus provides a survival factor to Burkitt's lymphomas Proc. Natl. Acad. Sci. U.S.A. 100 24 2003 14269 14274
17. E. Kieff Epstein-Barr virus and its replication B. Fields D. Knipe P. Howley Fields Virology 3rd ed. 1996 Lippincott-Raven Press Philadelphia
18. B. Ledergerber, A. Telenti, and M. Egger Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study BMJ 319 7201 1999 23 24
19. M.A. Lee, M.E. Diamond, and J.L. Yates Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus J. Virol. 73 4 1999 2974 2982
20. T. Maniatis, E.F. Fritsch, and J. Sambrook Molecular Cloning: A Laboratory Manual 1982 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
21. G. Miller Epstein-Barr virus B.N. Fields D.M. Knipe Virology 1990 Raven Press New York
22. K.W. Moore, P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI Science 248 4960 1990 1230 1234
23. M. Nasimuzzaman, M. Kuroda, S. Dohno, T. Yamamoto, K. Iwatsuki, S. Matsuzaki, R. Mohammad, W. Kumita, H. Mizuguchi, T. Hayakawa, H. Nakamura, T. Taguchi, H. Wakiguchi, and S. Imai Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1 Mol. Ther. 11 4 2005 578 590
24. C.D. Novina, M.F. Murray, D.M. Dykxhoorn, P.J. Beresford, J. Riess, S.K. Lee, R.G. Collman, J. Lieberman, P. Shankar, and P.A. Sharp siRNA-directed inhibition of HIV-1 infection Nat. Med. 8 7 2002 681 686
25. G. Randall, A. Grakoui, and C.M. Rice Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs Proc. Natl. Acad. Sci. U.S.A. 100 1 2003 235 240
26. J.B. Wilson, J.L. Bell, and A.J. Levine Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice EMBO J. 15 12 1996 3117 3126
27. L.S. Young, and M. Rowe Epstein-Barr virus, lymphomas and Hodgkin's disease Semin. Cancer Biol. 3 5 1992 273 284
28. L.S. Young, C.W. Dawson, and A.G. Eliopoulos The expression and function of Epstein-Barr virus encoded latent genes Mol. Pathol. 53 5 2000 238 247